The Register · A provider
Maria Skłodowska-Curie National Research Institute of Oncology
Warsaw, Gliwice, Kraków · Poland
Specialties
Reports that name this provider
- Chemotherapy & Immunotherapy Quality in Poland
- Manages 25% of Polish cancer patients; ESMO Designated Centre of Integrated Oncology and Palliative Care (2023-2025); conducts over 650 clinical trials including 80+ early-phase trials. Warsaw campus: 741 beds, 130,000+ patients/year, 680,000 outpatient consultations. Gliwice branch: 500 beds, ~45,500 patients/year, 206,000+ consultations, 120+ clinical trials (phases 1b-4), Molecular Laboratory (Centre of Excellence by Affymetrix). 86% 5-year breast cancer survival rate.
- Clinical Trial Access in Poland
- Manages over 650 active clinical trials including 80 early-phase trials; handles 25% of all cancer patients in Poland; processes 130,000 hospitalizations, 680,000 outpatient consultations, and 50,000 new diagnoses annually; member of EORTC, ELNET, and the European Lymphoma Institute
- Integrative Oncology Quality in Poland
- Three campuses. Warsaw: Psycho-Oncology Clinic (established 2011, first in Poland; 31-member team including psychiatrists, psychologists, psychotherapists, social workers) and Dietetic Clinic headed by Dr. Aleksandra Kapała offering cachexia management and peri-operative nutrition. Gliwice: Rehabilitation Workshop with kinesiotherapy, manual lymphatic drainage, deep oscillation therapy, sequential pneumatic compression, kinesiology taping. Free services under National Health Fund (NFZ). ESMO-designated centre for integrated oncology and palliative care.
- Oncologic Surgery Quality in Poland
- 741 beds across three campuses; OECI full member; European Reference Network (Endo-ERN) reference center for rare endocrine tumors; ESO Clinical Training Centre; handles over 130,000 hospitalizations annually; 28 clinical departments in Warsaw; manages over 650 active clinical trials including 80 early-phase studies; oldest and largest thyroid cancer centre in Poland, managing over 15,000 thyroid cancer patients in ongoing follow-up; performs more than 200 thyroidectomies and approximately 100 lateral neck lymph node dissections annually; capable of tracheal reconstruction; ESMO-accredited centre of integrated oncology and palliative care for 2023-2025
- Pathology Quality in Poland
- ESMO Designated Centre of Integrated Oncology and Palliative Care; treats approximately 25% of all cancer patients in Poland (over 130,000 hospitalized patients annually); includes Department of Pathology and Molecular Medicine and Flow Cytometry Laboratory
- Second Opinion Services in Poland
- Poland's leading cancer center with 28 clinical departments covering all major tumor types. Holds ESMO Designated Centre of Integrated Oncology and Palliative Care status. Collaborates with ESMO, EORTC, ESTRO, ASCO, and IARC. Serves as European Reference Network (EURACAN) reference center for rare cancers.